Halving heart failure outcomes by finerenone-mediated type 2 diabetes prevention
Lancet Diabetes Endocrinol
.
2025 Jan 13:S2213-8587(24)00317-6.
doi: 10.1016/S2213-8587(24)00317-6.
Online ahead of print.
Authors
Hertzel C Gerstein
1
,
Kamel Mohammedi
2
Affiliations
1
Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton L8S 4K1, ON, Canada. Electronic address:
[email protected]
.
2
University of Bordeaux, INSERM, BMC, U1034, Pessac, France.
PMID:
39818227
DOI:
10.1016/S2213-8587(24)00317-6
No abstract available